Month: January 2025

Learn about the approval status of lenacapavir in India, its licensing agreements with Indian manufacturers, global approvals, and the ongoing patent challenges affecting its availability

Discover how lenacapavir, a long-acting HIV drug, targets the viral capsid to block replication, offering innovative treatment options with biannual dosing